Royalty Pharma plc (NasdaqGS: RPRX)
Health Care · Pharmaceuticals · US
$61.80
-0.43% today · +71.8% 1Y
Royalty Pharma plc (NasdaqGS: RPRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.52B and employs 100 people.
Over the last twelve months the share price has gained 71.8%, trading between 34.08 and 61.80.
Tweenvest scores Royalty Pharma plc across four factors: quality 67/100, value 38/100, growth 27/100, dividend 75/100. Its strongest factor is dividend.
RPRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.52B
- Revenue (TTM)
- $2.54B
- P/E
- 33.15
- EPS
- 1.86
- Dividend yield
- 1.51%
- Beta (5Y)
- 0.43
- 52-week high
- $61.80
- 52-week low
- $34.08
- Avg volume (3M)
- —
- Shares outstanding
- 445.28M
- Employees
- 100
- Next earnings
- —
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
- ISIN
- GB00BMVP7Y09
- Founded
- 1996
- Listed since
- Jun 16, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.